Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study.

Gupta R, Islam S, Mony P, Kutty VR, Mohan V, Kumar R, Thakur JS, Shankar VK, Mohan D, Vijayakumar K, Rahman O, Yusuf R, Iqbal R, Shahid M, Mohan I, Rangarajan S, Teo KK, Yusuf S.

Eur J Prev Cardiol. 2015 Oct;22(10):1261-71. doi: 10.1177/2047487314540386. Epub 2014 Jun 18.

PMID:
24942224
2.

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.

Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, Gupta R, Kelishadi R, Iqbal R, Avezum A, Kruger A, Kutty R, Lanas F, Lisheng L, Wei L, Lopez-Jaramillo P, Oguz A, Rahman O, Swidan H, Yusoff K, Zatonski W, Rosengren A, Teo KK; Prospective Urban Rural Epidemiology (PURE) Study Investigators.

Lancet. 2011 Oct 1;378(9798):1231-43. doi: 10.1016/S0140-6736(11)61215-4. Epub 2011 Aug 26.

PMID:
21872920
3.

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.

Khatib R, McKee M, Shannon H, Chow C, Rangarajan S, Teo K, Wei L, Mony P, Mohan V, Gupta R, Kumar R, Vijayakumar K, Lear SA, Diaz R, Avezum A, Lopez-Jaramillo P, Lanas F, Yusoff K, Ismail N, Kazmi K, Rahman O, Rosengren A, Monsef N, Kelishadi R, Kruger A, Puoane T, Szuba A, Chifamba J, Temizhan A, Dagenais G, Gafni A, Yusuf S; PURE study investigators.

Lancet. 2016 Jan 2;387(10013):61-9. doi: 10.1016/S0140-6736(15)00469-9. Epub 2015 Oct 20.

PMID:
26498706
4.

Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study.

Tang X, Laskowitz DT, He L, Østbye T, Bettger JP, Cao Y, Li N, Li J, Zhang Z, Liu J, Yu L, Xu H, Hu Y, Goldstein LB.

Int J Stroke. 2015 Apr;10(3):388-95. doi: 10.1111/ijs.12343. Epub 2014 Aug 4.

5.

Socioeconomic status and COPD among low- and middle-income countries.

Grigsby M, Siddharthan T, Chowdhury MA, Siddiquee A, Rubinstein A, Sobrino E, Miranda JJ, Bernabe-Ortiz A, Alam D, Checkley W.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 5;11:2497-2507. eCollection 2016.

7.

Prevalence of Body Mass Index Lower Than 16 Among Women in Low- and Middle-Income Countries.

Razak F, Corsi DJ, Slutsky AS, Kurpad A, Berkman L, Laupacis A, Subramanian SV.

JAMA. 2015 Nov 24;314(20):2164-71. doi: 10.1001/jama.2015.15666. Erratum in: JAMA. 2016 Jan 12;315(2):204.

PMID:
26599184
8.

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study.

Vedin O, Hagström E, Stewart R, Brown R, Krug-Gourley S, Davies R, Wallentin L, White H, Held C.

Eur J Prev Cardiol. 2013 Aug;20(4):678-85. doi: 10.1177/2047487312444995. Epub 2012 Apr 10.

PMID:
22496275
9.

Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge.

Jin H, Tang C, Wei Q, Chen L, Sun Q, Ma G, Liu N.

BMC Cardiovasc Disord. 2014 Sep 24;14:127. doi: 10.1186/1471-2261-14-127.

10.

Association of Household Wealth Index, Educational Status, and Social Capital with Hypertension Awareness, Treatment, and Control in South Asia.

Gupta R, Kaur M, Islam S, Mohan V, Mony P, Kumar R, Kutty VR, Iqbal R, Rahman O, Deepa M, Antony J, Vijaykumar K, Kazmi K, Yusuf R, Mohan I, Panwar RB, Rangarajan S, Yusuf S.

Am J Hypertens. 2017 Apr 1;30(4):373-381. doi: 10.1093/ajh/hpw169.

PMID:
28096145
11.

Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China: China Kadoorie Biobank Study of 0.5 million people.

Chen Y, Li L, Zhang Q, Clarke R, Chen J, Guo Y, Bian Z, Pan X, Peto R, Tao R, Shi K, Collins R, Ma L, Sun H, Chen Z; China Kadoorie Biobank Study.

Int J Cardiol. 2014 Mar 1;172(1):88-95. doi: 10.1016/j.ijcard.2013.12.065. Epub 2013 Dec 28.

12.

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.

Kotseva K, Wood D, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, Amouyel P, Bruthans J, Castro Conde A, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators.

Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.

PMID:
25687109
13.

Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study.

Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, Rosengren A, Lopez-Jaramillo P, Diaz R, Oliveira G, Miskan M, Rangarajan S, Iqbal R, Ilow R, Puone T, Bahonar A, Gulec S, Darwish EA, Lanas F, Vijaykumar K, Rahman O, Chifamba J, Hou Y, Li N, Yusuf S; PURE Investigators.

JAMA. 2013 Apr 17;309(15):1613-21. doi: 10.1001/jama.2013.3519.

PMID:
23592106
14.

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.

Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC.

Vasc Health Risk Manag. 2009;5:1007-14. Epub 2009 Nov 23.

15.
17.

Secondary CV Prevention in South America in a Community Setting: The PURE Study.

Avezum A, Oliveira GBF, Lanas F, Lopez-Jaramillo P, Diaz R, Miranda JJ, Seron P, Camacho-Lopez PA, Orlandini A, Bernabe-Ortiz A, Cordeiro Mattos A, Islam S, Rangarajan S, Teo K, Yusuf S.

Glob Heart. 2017 Dec;12(4):305-313. doi: 10.1016/j.gheart.2016.06.001. Epub 2016 Oct 20.

PMID:
27773540
18.

Obstacles and alternative options for cardiac rehabilitation in Nanjing, China: an exploratory study.

Jin H, Wei Q, Chen L, Sun Q, Zhang Y, Wu J, Ma G, Liu N.

BMC Cardiovasc Disord. 2014 Feb 17;14:20. doi: 10.1186/1471-2261-14-20.

19.

Demographics, socio-economic characteristics, and risk factor prevalence in patients with non-cardioembolic ischaemic stroke in low- and middle-income countries: the OPTIC registry.

Abboud H, Labreuche J, Arauz A, Bryer A, Lavados PG, Massaro A, Munoz Collazos M, Steg PG, Yamout BI, Vicaut E, Amarenco P; OPTIC Registry Investigators.

Int J Stroke. 2013 Oct;8 Suppl A100:4-13. doi: 10.1111/j.1747-4949.2012.00893.x. Epub 2012 Sep 13.

PMID:
22974118
20.

Supplemental Content

Support Center